Bottle Label 60 mg (71610 0504 60)
Raloxifene Hydrochloride
Product Images NDC 71610-504
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71610-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
\\client\x$\products\raloxifene Hydrochloride Tabs Anda 078193\submissions\2016-03-18 Cbe-0 (AJK\Working\INSERT\Image File\raloxifene-structure01.jpg)
\\client\x$\products\raloxifene Hydrochloride Tabs Anda 078193\submissions\2016-03-18 Cbe-0 (AJK\Working\INSERT\Image File\raloxifene-figure01.JPG)
Total hip mean percentage change from baseline data is presented for subjects who received either placebo or raloxifene hydrochloride over a period of 24 months in Studies A and EU. The data is also presented for the same subjects along with those who received conjussted strogens 0.625 mg/day in Study INT (hysterectomized women). An analysis was carried out using a treatment-to-treat approach with left observation.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
